After its successful 2018 campaign, Amcal Pharmacy has announced it has teamed up with Mobil 1 MEGA Racing Supercars driver Jack Perkins for another term.
Last year saw Mr Perkins give his audience new insight into how he manages his diabetes, with the program now set to officially relaunch again this month.
The relaunch will feature a renewed focus on breaking down attitudinal barriers for the more than 630,000 Australians living with the condition.
Amcal General Manager, Brian Tomlin, noted the importance of highlighting the realities of living with, and the importance of, managing diabetes.
“Our research into diabetes indicates that negative attitudes and misconceptions among the general public regarding diabetes largely still exists,” he said.
“For example, more than a quarter of Australians still consider diabetes to be a self-inflicted disease and a burden on the health system.
“By inviting Australians into Jack’s diabetes journey, we are able to humanise and amplify the possibilities when living with diabetes along with connecting and speaking directly with those Australians who may feel isolated,” said Mr Tomlin.
This year will see Perkins build on the momentum from last year’s campaign to help elevate Amcal’s broader strategic vision of providing trusted and accessible healthcare even further, according to Tomlin.
“This year, we will be bigger and bolder in our ambitions to reach thousands of Australians to talk to them about diabetes risk factors, common indicators and overall condition management,” said Mr Tomlin.
“To do this, we will be engaging Perkins on multiple racing and speaking opportunities over the remainder of the year to ensure we are debunking the myths of this condition ongoing.
“At a strategic level, Perkins will be championing Amcal with dedicated video and social content as well as select in-store appearances to help highlight our convenient and reliable screening services,” he said.
Jack Perkins said he was thrilled to team up again with Amcal and highlight the importance of destigmatising this condition.
“I am beyond excited to build on the success of last year and show how diabetes should not be viewed as a barrier or limitation in achieving professional and personal success,” said Mr Perkins.
To help people better manage their condition, Mr Tomlin is encouraging those who may be at risk to seek out relevant health advice, including from Amcal pharmacists.
“Amcal is committed to providing front-line support alongside GPs and other healthcare professionals to those at risk of developing diabetes and helping those who live with the condition to better manage their health,” he said.